What does the PEG in PEG-MGF do?

The polyethylene glycol group shields the peptide from enzymes and slows clearance, giving PEG-MGF a much longer half-life than native MGF so it stays active in circulation for an extended period.

How is PEG-MGF dosed differently from regular MGF?

Because of its extended half-life, research protocols dose PEG-MGF less frequently, often a few times per week, whereas native MGF is typically used locally and more often.

Is PEG-MGF approved for human use?

No. It is an unapproved research chemical and should only be handled in laboratory research contexts.

← All peptides

Muscle Growth

Research Chemical

PEG-MGF

Also known as: PEG-MGF, PEG MGF, Pegylated MGF

PEG-MGF is a pegylated form of Mechano Growth Factor engineered for greater stability and a longer systemic half-life than native MGF. It is studied for muscle stem cell activation and recovery.

Mechanism of Action

PEG-MGF attaches a polyethylene glycol (PEG) moiety to the MGF peptide, dramatically slowing enzymatic degradation and renal clearance so the molecule persists in circulation far longer than unmodified MGF. Like native MGF it carries the IGF-1Ec C-terminal E-domain, which recruits and proliferates satellite cells and delays their differentiation to expand the repair-capable stem cell pool. The pegylation shifts MGF from a strictly local, transient signal toward a more systemic, sustained exposure in research models. This extended availability is the rationale for less frequent dosing compared with native MGF.

Half-life: Extended versus native MGF, on the order of hours to a day
Administration Routes: subcutaneous
Research Status: Research Chemical